2.2.4. Cholinesterase Flashcards

1
Q

Distinguishing Characteristics of the Somatic Nervous System

A
  1. One neuron in the efferent pathway
  2. Excitatory effects
  3. Releases ACh (nicotinic receptor) OR Norepinephrine (alpha or beta receptor)
  4. Targets skeletal muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Distinguishing Characteristics of the AutonomicNervous System

A
  1. Two neurons in the efferent pathway
  2. Excitatory/inhibitory effects
  3. Releases ACh (muscarinic receptor)
  4. Targets smooth or cardiac muscle, some exocrine/endocrine glands, and some adipose tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Two types of cholinesterases

A
  1. Acetylcholinesterase

2. Plasma Cholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

AChE

A
  1. Present at synapses
  2. Predominant form is anchored to the extracellular matrix, near ACh receptors
  3. One of the fastest enzymes
  4. DOES NOT hydrolyze butyrylcholine
  5. One gene product
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Plasma Cholinesterase

A

(pseudocholinesterase, butyrylcholinesterase)

  1. Made in the liver and secreted into the blood
  2. Hydrolyzes butyrylcholine as well as it hydrolyzes ACh
  3. Relevant if ACh or ACh-like drugs pass through the bloodstream
  4. Considerable polymorphism in humans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Two examples of ACh-like drugs?

A
  1. Succinylcholine: a neuromuscular blocker

2. Procaine: ester-type anesthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the active site “gorge” of AChE?

A

Serine Hydrolase (critical serine in esteric site)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is the acyl intermediate (formed after the enzymatic reaction with ACh) short lived?

A

Regeneration by nucleophilic attack of water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Therapeutic Goal of AChE inhibitors

A

To increase ACh neurotransmission at specific sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinically used AChE inhibitors

A
  1. Edrophonium (quaternary alcohols)
  2. Neostigmine, Pyridostigmine, Physostigmine, Ambenonium, Demecarium (carbamates)
  3. Donezepil, Galantamine (atypicals)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Organophosphates

A

Clinically used: DFP (diisopropyl fluorophosphate), echothiphate

Insecticides: paraoxon, malaoxon, parathion, malathion, etc.

Nerve gas: sarin, soman

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Effects of Increased ACh on the Heart

A
  • Decreased heart rate
  • Decreased conduction and contraction
  • Slower cardiac rhythm (due to cardiac muscle hyperpolarization)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vascular effects of increased ACh

A

Arteriolar vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Smooth muscle effects of increased ACh

A
  • Increased intestinal tone with peristaltic contraction
  • Increased ureter tone
  • Bronchoconstriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Results of Increased ACh on secretions

A

-increased saliva, sweat and lacrimal secretions (lubricates the surface of the eye)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ocular Effects of Increased ACh

A

Decrease of iris diameter (miosis) and lower intra-ocular pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Increased ACh at the neuromuscular junction

A
  • low concentration = muscle contraction

- high concentration = inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Anticholinesterases that treat Myasthenia gravis

A

Target: NMJ

Edrophonium (diagnosis)

Pyridostigmine, Neostigmine, and Ambemonium (treatment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Anticholinesterases that treat Anesthesia

A

Target: NMJ (after medical procedure is completed)

Edrophonium and Pyridostigmine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Anticholinesterases that treat Alzheimer’s disease

A

Target: basal forebrain (cognition enhancement)

Donepezil, Rivastigmine, Galantamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Anticholinesterases that treat Glaucoma

A

Target: iris sphincter (local activation of muscarinic receptors to trigger constriction, aka miosis, leading to aqueous outflow)

Physostigmine, Echothiophate, Demacarium, Diisoflurophosphate (DFP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Anticholinesterases used in Emergency Medicine

A

Physostigmine

Used to reverse the psychosis caused by an overdose of anti-cholinergics or antihistamines

23
Q

Anticholinesterases that help with bladder control

A

Neostigmine

Localized reversal of atony of the bladder

24
Q

Anticholinesterases that treat Dry Mouth

A

Physostigmine gel

25
Chemistry behind Anticholinesterases
Acyl intermediate is LONG LIVED
26
AChE + ACh
Half-life of the intermediate is several microseconds
27
AChE + Carbamate
Half-life of the intermediate is 15 to 20 minutes
28
AChE + Organophosphate
Half-life of the intermediate is several hours or days
29
Carbamates vs. Organophosphates
Carbamates typically do not have adverse effects. Organophosphates (like Donezepil which is used to treat Alzheimer's) have multiple adverse effects
30
Edrophonium
Used to diagnosis Myasthenia Gravis
31
Myasthenia Gravis
Patients have autoantibodies against nicotinic ACh receptors, resulting in reduced neurotransmission Drooping eyelids, double vision, and muscle weakness
32
Pyridostigmine
Used to treat Myasthenia Gravis. Unlike Edrophonium, this drug is active for much longer and has adverse affects associated with the GI tract
33
Alzheimer's Disease
Patients have reduced neurotransmission, believed to include deficiency of cholinergic neurons; secondary effects are believed to be due to reduced inflammation in the CNS
34
Administration of Donezipil, Rivastigmine, and Galantimine
Alzheimer Treatment - therapeutic dosage requires 15 days, including a 1 week titration to avoid adverse effects - Donepezil and Galantamine are NOT metabolized by butyrylcholinesterase, but rather by cytochrome P450 (CYP2D6 and CYP3A4)
35
Echothiphate, DFP, Physostigimine, Demecarium
Glaucoma Treatment These drugs are no longer the first-line treatment, due to potential toxic side effect
36
Scopolamine and Atropine
Block binding of ACh to nicotinic receptors. Physostigmine is used to reverse their effect.
37
Benadryl and Dramamine
AKA diphenhydramine and dimethylhydrinate Anti-cholinergic activity at high doses
38
Hypocholinergic symptoms
Dry, hot, mydriasis (dilation of the pupil), hallucination, and muscle weakness
39
Hypercholinergic symptoms
Secretion, miosis (contraction of the pupil), cramps, muscle twitches
40
Chemically, why are organophosphates so toxic?
De-alkylation of the phosphate (aka "aging") leads to irreversible intermediate that can never be cleaved by water
41
Cholinergic Syndrome/Crisis
Poisoning by anti-AChE agents
42
What are the 2 chronic effects of organophosphate poisoning?
1. Intermediate syndrome | 2. OPIDP (OrganoPhosphate-Induced Delayed Polyneuropathy)
43
Intermediate Syndrome
Symptoms occur for up to a week after OP exposure. Modification in the function of nicotinic receptors at the NMJ caused by excess levels of ACh. Symptoms do NOT respond to atropine, and 2-PAM is NOT indicated. Symptoms resolve on their own after a week or two.
44
ODIDP
Muscle weakness, headaches, psychiatric problems, memory problems, etc. Likely cause is the inhibition of AChE-like serine esterase called "neuropathy target esterase" or NTE No established pharmaceutical therapy
45
Goal of treatments for organophosphate poisoning
1. Decontamination 2. Stop secretion 3. Release AChE enzymes from inhibition 4. Stop convulsions; supportive care
46
Atropine
Muscarinic receptor inhibitor, used immediately to treat OP in order to stop secretions
47
Pralidoxime (2-PAM)
Used immediately to regenerate the enzyme (used before "aging")
48
Diazepam
Used to reduce convulsions by inhibiting neurotransmissions
49
Why is it hard to protect someone from nerve gas poisoning?
1. Some OPs undergo rapid aging, making pralidoxime (2-PAM) ineffective 2. The symptoms of AChE poisoning does not appear until more than 50% of the activity of AChE has been inhibited
50
How do you protect someone from nerve gas poisoning?
Inhibit a fraction of AChE with a spontaneously reversible anti-AChE (e.g., pyridostigmine) BEFORE an anticipated soman exposure
51
Agents similar to 2-PAM
HI-6 (smaller dose, but ineffective against GA and paraoxon) HLo-7 (effective against GA and a smaller dose, but higher reactivation after exposure) MMB4 (smaller dose than 2-PAM)
52
Why do we use Malathion to kill bugs?
The "prodrug" activity of malathion (an insecticide) is higher in bugs than it is in people Parathion, along with malathion, do not persist in the environment very long because the phosphate hydrolyzes rapidly, but acute toxicity is a considerable risk to farm laborers and animals
53
Soman (GD)
Poisoning is extremely difficult to reverse because the cholinesterase rapidly develops a stable monoalkyl bond that resists regeneration (it undergoes rapid aging)